FLNG

SEC source: 0000919574-26-006389 · ownership.xml · derivative · entry 1

Traaholt Knut · CIK 0002021394 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,614

Underlying: Cash-settled synthetic option · Not disclosed shares

Expires 2030-06-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On September 17, 2026, the reporting person exercised 20,348 vested synthetic options for cash settlement pursuant to the Issuer's Synthetic Option Scheme. The cash settlement value was determined based on the closing price of the Issuer's ordinary shares on the New York Stock Exchange on September 17, 2026 of $32.52 per share less the strike price of $20.00 per synthetic share option, which reflects adjustments made pursuant to the Issuer's Synthetic Option Scheme, including adjustments for dividends. No ordinary shares were issued upon exercise.

F2 · derivative.exercise_date: The reported exercise relates to the first tranche of synthetic options granted on June 24, 2025 under the Issuer's Synthetic Option Scheme. This tranche consisted of 20,348 synthetic options, all of which vested on June 24, 2026 and became exercisable upon vesting. The synthetic options issued pursuant to the Issuer's Synthetic Option Scheme vest over a three-year period in increments of one-third per annum with initial vesting on June 24, 2026 and subsequent vesting on June 24, 2027 and June 24, 2028.

F3 · derivative.underlying_shares: The reported securities are cash-settled synthetic options granted under the Issuer's Synthetic Option Scheme and do not represent a right to acquire ordinary shares of the Issuer.

SEC source: 0000919574-26-005665 · ownership.xml · derivative · entry 1

Foss Halfdan Marius · CIK 0002117539 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,042

Underlying: Cash-settled synthetic option · Not disclosed shares

Expires 2030-06-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On August 20, 2026, the reporting person exercised 27,575 vested synthetic options for cash settlement pursuant to the Issuer's Synthetic Option Scheme. The cash settlement value was determined based on the closing price of the Issuer's ordinary shares on the New York Stock Exchange on August 19, 2026 of $32.48 per share less the strike price of $20.75 per synthetic share option, which reflects adjustments made pursuant to the Issuer's Synthetic Option Scheme, including adjustments for dividends. No ordinary shares were issued upon exercise.

F2 · derivative.exercise_date: The reported exercise relates to the first tranche of synthetic options granted on June 24, 2025 under the Issuer's Synthetic Option Scheme. This tranche consisted of 27,575 synthetic options, all of which vested on June 24, 2026 and became exercisable upon vesting. The synthetic options issued pursuant to the Issuer's Synthetic Option Scheme vest over a three-year period in increments of one-third per annum with initial vesting on June 24, 2026 and subsequent vesting on June 24, 2027 and June 24, 2028.

F3 · derivative.underlying_shares: The reported securities are cash-settled synthetic options granted under the Issuer's Synthetic Option Scheme and do not represent a right to acquire ordinary shares of the Issuer.

SEC source: 0000919574-26-004137 · ownership.xml · derivative · entry 1

Foss Halfdan Marius · CIK 0002117539 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,617

Underlying: Cash-settled synthetic option · Not disclosed shares

Expires not disclosed

F2 · derivative.exercise_price: The synthetic options were granted with an initial exercise price of $30.00 per option, subject to adjustment pursuant to the terms of the Issuer's Synthetic Option Scheme. No consideration was paid for the grant of the synthetic options.

F1 · derivative.exercise_date: On June 23, 2026, the Board approved the grant of 111,893 synthetic options under the Issuer's Synthetic Option Scheme. The options vest in three equal annual installments on June 24, 2027, June 24, 2028 and June 24, 2029 and expire on June 24, 2031.

F1 · derivative.expiration_date: On June 23, 2026, the Board approved the grant of 111,893 synthetic options under the Issuer's Synthetic Option Scheme. The options vest in three equal annual installments on June 24, 2027, June 24, 2028 and June 24, 2029 and expire on June 24, 2031.

F3 · derivative.underlying_shares: The reported securities are cash-settled synthetic options granted under the Issuer's Synthetic Option Scheme and do not represent a right to acquire ordinary shares of the Issuer.

SEC source: 0000919574-26-004134 · ownership.xml · derivative · entry 1

Traaholt Knut · CIK 0002021394 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,962

Underlying: Cash-settled synthetic option · Not disclosed shares

Expires not disclosed

F2 · derivative.exercise_price: The synthetic options were granted with an initial exercise price of $30.00 per option, subject to adjustment pursuant to the terms of the Issuer's Synthetic Option Scheme. No consideration was paid for the grant of the synthetic options.

F1 · derivative.exercise_date: On June 23, 2026, the Board approved the grant of 83,919 synthetic options under the Issuer's Synthetic Option Scheme. The options vest in three equal annual installments on June 24, 2027, June 24, 2028 and June 24, 2029 and expire on June 24, 2031.

F1 · derivative.expiration_date: On June 23, 2026, the Board approved the grant of 83,919 synthetic options under the Issuer's Synthetic Option Scheme. The options vest in three equal annual installments on June 24, 2027, June 24, 2028 and June 24, 2029 and expire on June 24, 2031.

F3 · derivative.underlying_shares: The reported securities are cash-settled synthetic options granted under the Issuer's Synthetic Option Scheme and do not represent a right to acquire ordinary shares of the Issuer.